MEN11467 is a selective non-peptide antagonist of the bradykinin B2 receptor, primarily used in research settings to study its potential as a therapeutic agent. It is investigated for its role in modulating bradykinin-mediated responses, which can help in understanding physiological processes such as inflammation, pain, and vascular permeability, as well as disease mechanisms. Its application is particularly relevant in the field of pharmacology, where it is explored for its efficacy in conditions like inflammatory diseases, asthma, or angioedema. Additionally, MEN11467 serves as a valuable tool in preclinical studies to assess safety, pharmacokinetics, and pharmacodynamics, contributing to the advancement of drug discovery and development.